HepatoScore-14: Measures of biological heterogeneity significantly improve prediction of hepatocellular carcinoma risk

BACKGROUND & AIMS: Therapeutic, clinical trial entry and stratification decisions for hepatocellular carcinoma (HCC) are made based on prognostic assessments, using clinical staging systems based on small numbers of empirically selected variables that insufficiently account for differences in bi...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Hepatology
Prif Awduron: Morris, Jeffrey S., Hassan, Manal M., Zohner, Ye Emma, Wang, Zeya, Xiao, Lianchun, Rashid, Asif, Haque, Abedul, Abdel-Wahab, Reham, Mohamed, Yehia A., Ballard, Karri L., Wolff, Robert A., George, Bhawana, Li, Liang, Allen, Genevera, Weylandt, Michael, Li, Donghui, Wang, Wenyi, Raghav, Kanwal, Yao, James, Amin, Hesham M., Kaseb, Ahmed Omar
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2021
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7956911/
https://ncbi.nlm.nih.gov/pubmed/32931023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.31555
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg